Conversations that Convert
Explore the results of OptimizeRx 2024 physician survey on pharma marketing perception and impact – including the untapped opportunity of HCP and DTC marketing alignment.
Conversations that Convert
Explore the results of OptimizeRx 2024 physician survey on pharma marketing perception and impact – including the untapped opportunity of HCP and DTC marketing alignment.
Ideas, Insights, and Inspiration for Modern Healthcare Marketers
Explore our full library of resources developed by healthcare industry leaders aimed to spark actionable ideas.
Let's Talk
Want patients and providers talking about your brand? Talk to us first.
Insights on Omnichannel, AI and Next-Best Action in HCP Engagement
The phrases “omnichannel,” “artificial intelligence” and “next-best action” have become ubiquitous in conversations around how to overcome the challenges of reaching HCPs and, ultimately, their patients. But what do those on the front...
It’s Time to End Multi-Trigger Targeting for EHR-based HCP Engagement
In life science brands’ quest for highly targeted, clinically-relevant HCP communications, EHR “trigger” data is an increasingly popular choice. Its benefits include accuracy and control over message deployment, but many brands don’t...
Realizing Point-of-Care Opportunities: eBook Insights from EHR Experts
Navigating the EHR Landscape: Market Challenges and Point-of-Care Solution Life science brand’s need for effective HCP engagement solutions at the point of care (POC) is critical. The American Medical Informatics Association’s (AMIA)...
How Integrated Is Your Omnichannel Strategy? Here’s a Quick Guide
Omnichannel programs are at the forefront of today’s HCP engagement strategies – and for good reason. In a March 2023 survey, OptimizeRx found that physicians were actively engaging with life science brand content across 10+ digital and...
Planning for Pharma LOE? The Digital Point-of-Care Makes a Difference
Loss of exclusivity (LOE) is a milestone every novel pharmaceutical product reaches. In anticipation of generic competition and the resulting loss of market share/value, manufacturers take a variety of approaches – from next-gen products...
